Medical Oncology

James Abbruzzese, MD

Professor of Medicine
D. C. I. Professor of Medical Oncology
Chief, Division of Medical Oncology
Member of the Duke Cancer Institute
Campus mail 440 Mudd Building, Box 3406, Durham, NC 27710
Email address james.abbruzzese@duke.edu

My research interests include the clinical study and treatment of pancreatic cancer.

In Their Words

Education and Training

  • Resident, Internal Medicine, Johns Hopkins University School of Medicine, 1979 - 1981
  • Intern, Internal Medicine, Johns Hopkins University School of Medicine, 1978 - 1979
  • M.D., University of Chicago, 1978

Grants

Publications

Stuti, S, Shroff, S, Overman, MJ, Rashid, A, Shroff, RT, Wang, H, Chatterjee, D, Katz, MH, Lee, JE, Wolff, RA, Abbruzzese, JL, Fleming, JB, and Wang, H. "The expression of pten is associated with improved prognosis in patients with ampullary adenocarcinoma after pancreaticoduodenectomy." Archives of Pathology and Laboratory Medicine 137, no. 11 (November 1, 2013): 1619-1626.

Full Text

Varadhachary, GR, Lenzi, R, Raber, MN, and Abbruzzese, JL. "Carcinoma of Unknown Primary." In Abeloff's Clinical Oncology: Fifth Edition, 1792-1803.e2. October 22, 2013.

Full Text

Khalil, MA, Qiao, W, Carlson, P, George, B, Javle, M, Overman, M, Varadhachary, G, Wolff, RA, Abbruzzese, JL, and Fogelman, DR. "The addition of erlotinib to gemcitabine and cisplatin does not appear to improve median survival in metastatic pancreatic cancer." Investigational new drugs 31, no. 5 (October 2013): 1375-1383.

PMID
23645398
Full Text

Kaseb, AO, Shindoh, J, Patt, YZ, Roses, RE, Zimmitti, G, Lozano, RD, Hassan, MM, Hassabo, HM, Curley, SA, Aloia, TA, Abbruzzese, JL, and Vauthey, J-N. "Modified cisplatin/interferon α-2b/doxorubicin/5-fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma." Cancer 119, no. 18 (September 2013): 3334-3342.

PMID
23821538
Full Text

Overman, MJ, Zhang, J, Kopetz, S, Davies, M, Jiang, Z-Q, Stemke-Hale, K, Rümmele, P, Pilarsky, C, Grützmann, R, Hamilton, S, Hwang, R, Abbruzzese, JL, Varadhachary, G, Broom, B, and Wang, H. "Correction: Gene Expression Profiling of Ampullary Carcinomas Classifies Ampullary Carcinomas into Biliary-Like and Intestinal-Like Subtypes That Are Prognostic of Outcome." Edited by J-S Lee. PLoS ONE 8, no. 7 (July 3, 2013).

Full Text

Tzeng, C-WD, Abbott, DE, Cantor, SB, Fleming, JB, Lee, JE, Pisters, PWT, Varadhachary, GR, Abbruzzese, JL, Wolff, RA, Ahmad, SA, and Katz, MHG. "Frequency and intensity of postoperative surveillance after curative treatment of pancreatic cancer: a cost-effectiveness analysis." Annals of surgical oncology 20, no. 7 (July 2013): 2197-2203.

PMID
23408126
Full Text

Foo, WC, Rashid, A, Wang, H, Katz, MH, Lee, JE, Pisters, PW, Wolff, RA, Abbruzzese, JL, Fleming, JB, and Wang, H. "Loss of phosphatase and tensin homolog expression is associated with recurrence and poor prognosis in patients with pancreatic ductal adenocarcinoma." Human pathology 44, no. 6 (June 2013): 1024-1030.

PMID
23260327
Full Text

Chang, Z, Li, Z, Wang, X, Kang, Y, Yuan, Y, Niu, J, Wang, H, Chatterjee, D, Fleming, JB, Li, M, Abbruzzese, JL, and Chiao, PJ. "Deciphering the mechanisms of tumorigenesis in human pancreatic ductal epithelial cells." Clinical cancer research : an official journal of the American Association for Cancer Research 19, no. 3 (February 2013): 549-559.

PMID
23340292
Full Text

Li, L, Othman, M, Rashid, A, Wang, H, Li, Z, Katz, MH, Lee, JE, Pisters, PW, Abbruzzese, JL, Fleming, JB, and Wang, H. "Solid pseudopapillary neoplasm of the pancreas with prominent atypical multinucleated giant tumour cells." Histopathology 62, no. 3 (February 2013): 465-471.

PMID
23134473
Full Text

Yao, Y, Suraokar, M, Darnay, BG, Hollier, BG, Shaiken, TE, Asano, T, Chen, C-H, Chang, BH-J, Lu, Y, Mills, GB, Sarbassov, D, Mani, SA, Abbruzzese, JL, and Reddy, SAG. "BSTA promotes mTORC2-mediated phosphorylation of Akt1 to suppress expression of FoxC2 and stimulate adipocyte differentiation." Science Signaling 6, no. 257 (January 8, 2013): ra2-null.

PMID
23300339
Full Text

Pages